Scheme 1
Scheme 2
reducing agents without significant reduction of either
carbonyl group. This observed electrophilicity at C-2 led us
to choose sulfur ylides as cyclopropanating agents for the
desired transformation. To this end, naphthyridone 8 was
treated with trimethylsulfoxonium iodide/sodium hydride in
DMSO (Scheme 3). Upon treatment with 1 equiv of the ylide,
Scheme 3
has become the method of choice for the synthesis of many
different ring systems.7,8 In the pharmaceutical industry,
discovery of azepine and diazepine peptidomimetics with
wide-ranging biological activities inspired many syntheses
of new seven-membered heterocycles. On the basis of the
wealth of published information, we anticipated that a method
or methods for the preparation of compounds of generic
structure 3 would be revealed.
Synthesis of the naphthyridone ring system is generally
accomplished by intramolecular nucleophilic aromatic sub-
stitution on a 2-chloropyridine as shown in Scheme 1.9
In a one-pot procedure, â-ketoester 4 is converted first to
vinyl ether 5 by reaction with triethyl orthoformate in acetic
anhydride. Removal of solvent followed by treatment of 5
with 2,4-dimethoxybenzylamine affords vinylogous imide 6,
which cyclizes upon addition of sodium hydride to provide
naphthyridone 7. Subsequent substitution at C-7 with pyr-
rolidine and sequential deprotection affords the N-1 unsub-
50% conversion to a single product occurred, with 50%
starting material remaining unreacted. Addition of a second
equivalent of ylide resulted in quantitative conversion to a
single product that was inconsistent with either a cyclopro-
pane or the corresponding ring-expansion product. Mass
spectrometry indicated a molecular weight of 562, consistent
with addition of one methylene group plus 1 equiv of the
sulfur ylide. Analysis of the product by multidimensional
NMR techniques, including COSY, ROESY, HSQC, and
HMBC, led to the identification of sulfur ylide 11 (Scheme
4) as the sole product of the reaction.11
10
stituted naphthyridone 2 of the lead series.
Scheme 2 illustrates an approach to analogues of lead
compound 2 via ring expansion of naphthyridone 8. In the
proposed sequence, simple access to compound 10 was
envisioned via cyclopropanation/ring expansion of naphthy-
ridone 8. Oxidation or isomerization of 10 would then
provide the desired R,â-unsaturated system. We had previ-
ously observed that naphthyridones such as compound 8
underwent selective 1,4-reduction with various borohydride
A proposed mechanism for the formation of 11 is
illustrated in Scheme 4. Apparently, the desired cyclopro-
panation reaction occurs to provide intermediate 9. However,
addition of a second equivalent of the sulfur ylide to the
keto group is more facile than ring expansion, and tetrahedral
intermediate 12 is formed. Under normal circumstances, 12
would be expected to form an epoxide by elimination of
dimethyl sulfoxide;12 however, in the proposed mechanism
(4) Bremner, J. B. Prog. Heterocycl. Chem. 2003, 15, 385-430.
(5) Scriven, E. F. V. Heterocycl. Chem. 1986, 5, 425-54.
(6) Kantorowski, E. J.; Kurth, M. J. Tetrahedron 2000, 56, 4317-4353.
(7) Furstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012-3043.
(8) Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413-4450.
(9) Chu, D. T. W.; Fernandes, P. B.; Claiborne, A. K.; Gracey, E. H.;
Pernet, A. G. J. Med. Chem. 29, 1986, 2364-2369.
(10) Wagner, R.; Weitzberg, M.; Sanders, W.; Clark, R.; Hinman, M.;
Rosenberg, T.; Motter, C.; Larsen, D.; Bosse, T.; Palazzo, F.; Keyes, R.
Manuscript in preparation.
(11) For references to a similar stable ylide, see: Beautement, K.; Clough,
J. M. Tetrahedron Lett. 1984, 25, 3025-3028.
(12) Trost, B. M.; Melvin, L. S. Sulfur Ylides: Emerging Synthetic
Intermediates; Academic Press: New York, 1975.
4528
Org. Lett., Vol. 6, No. 24, 2004